BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15782139)

  • 1. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
    Fujimoto E; Sato H; Shirai S; Nagashima Y; Fukumoto K; Hagiwara H; Negishi E; Ueno K; Omori Y; Yamasaki H; Hagiwara K; Yano T
    Oncogene; 2005 May; 24(22):3684-90. PubMed ID: 15782139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Src activity enhances the tumor-suppressive effect of the connexin 32 gene in Caki-1 renal cancer cells.
    Fujimoto E; Sato H; Shirai S; Nagashima Y; Virgona N; Hagiwara K; Yamasaki H; Negishi E; Ueno K; Yano T
    Oncol Rep; 2006 May; 15(5):1359-65. PubMed ID: 16596211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E; Sato H; Nagashima Y; Negishi E; Shirai S; Fukumoto K; Hagiwara H; Hagiwara K; Ueno K; Yano T
    Life Sci; 2005 Apr; 76(23):2711-20. PubMed ID: 15792837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
    Sato H; Hagiwara H; Senba H; Fukumoto K; Nagashima Y; Yamasaki H; Ueno K; Yano T
    Mol Carcinog; 2008 Jun; 47(6):403-9. PubMed ID: 18058801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
    Hagiwara H; Sato H; Shirai S; Kobayashi S; Fukumoto K; Ishida T; Seki T; Ariga T; Yano T
    Life Sci; 2006 Apr; 78(19):2249-54. PubMed ID: 16289236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.
    Fujimoto E; Satoh H; Negishi E; Ueno K; Nagashima Y; Hagiwara K; Yamasaki H; Yano T
    Mol Carcinog; 2004 Jul; 40(3):135-42. PubMed ID: 15224345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexin 32 expression reduces malignant phenotype in human A549 adenocarcinoma cells: Implication of Src involvement.
    Hada S; Sato H; Virgona N; Hagiwara H; Saito T; Suzuki K; Asano R; Yano T
    Oncol Rep; 2006 Nov; 16(5):1149-54. PubMed ID: 17016607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the Src family of kinases to the appearance of malignant phenotypes in renal cancer cells.
    Yonezawa Y; Nagashima Y; Sato H; Virgona N; Fukumoto K; Shirai S; Hagiwara H; Seki T; Ariga T; Senba H; Suzuki K; Asano R; Hagiwara K; Yano T
    Mol Carcinog; 2005 Aug; 43(4):188-97. PubMed ID: 15864803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling.
    Takano Y; Iwata H; Yano Y; Miyazawa M; Virgona N; Sato H; Ueno K; Yano T
    Biochem Pharmacol; 2010 Aug; 80(4):463-70. PubMed ID: 20510207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
    J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of the CpG island of connexin 32, a candiate tumor suppressor gene in renal cell carcinomas from hemodialysis patients.
    Yano T; Ito F; Kobayashi K; Yonezawa Y; Suzuki K; Asano R; Hagiwara K; Nakazawa H; Toma H; Yamasaki H
    Cancer Lett; 2004 May; 208(2):137-42. PubMed ID: 15142671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
    Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of secreted frizzled-related protein 3 in human renal cell carcinoma.
    Hirata H; Hinoda Y; Ueno K; Majid S; Saini S; Dahiya R
    Cancer Res; 2010 Mar; 70(5):1896-905. PubMed ID: 20160027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells.
    Sato H; Fukumoto K; Hada S; Hagiwara H; Fujimoto E; Negishi E; Ueno K; Yano T
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):449-57. PubMed ID: 17569045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the connexin 32 gene by epigallocatechin-3-gallate potentiates vinblastine-induced cytotoxicity in human renal carcinoma cells.
    Sato A; Sekine M; Kobayashi M; Virgona N; Ota M; Yano T
    Chemotherapy; 2013; 59(3):192-9. PubMed ID: 24335094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
    Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
    Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.